Fulltext

Strong additive effect of 1,25-dihydroxycholecalciferol and cyclosporine A but not tacrolimus in rat lung allotransplantation

Stammberger, Uz ; Kubisa, Bartosz ; Gugger, Matthias ; Ayuni, Erick ; Claudio, Redaelli ; Grodzki, Tomasz ; Schmid, Ralph Alexander

In: European Journal of Cardio-Thoracic Surgery, 2003, vol. 24, no. 2, p. 196-200

Aggiungi alla tua lista
    Titre
    • Strong additive effect of 1,25-dihydroxycholecalciferol and cyclosporine A but not tacrolimus in rat lung allotransplantation
    Auteur
    • Stammberger, Uz. Division of General Thoracic Surgery, University Hospital Berne, CH-3010 Berne, Switzerland
    • Kubisa, Bartosz. Division of General Thoracic Surgery, University Hospital Berne, CH-3010 Berne, Switzerland
    • Gugger, Matthias. Department of Pathology, University Hospital, Berne, Switzerland
    • Ayuni, Erick. Division of General Thoracic Surgery, University Hospital Berne, CH-3010 Berne, Switzerland
    • Claudio, Redaelli. Division of General Thoracic Surgery, University Hospital Berne, CH-3010 Berne, Switzerland
    • Grodzki, Tomasz. Division of Thoracic Surgery, Regional Hospital, Szczecin-Zdunowo, Poland
    • Schmid, Ralph Alexander. Division of General Thoracic Surgery, University Hospital Berne, CH-3010 Berne, Switzerland
    Type de document
    • Postprint
    Langue
    • Inglese
    Publié dans
    • European Journal of Cardio-Thoracic Surgery, 2003, vol. 24, no. 2, p. 196-200. Elsevier Science B.V.
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:298018
    Summary
    Objectives: 1,25-Dihydroxycholecalciferol (calcitriol, vitamin D3) has immunosuppressive properties. This study evaluates the effect of calcitriol in combination with either cyclosporine A or tacrolimus on acute lung allograft rejection in a rat model of unilateral left lung allotransplantation. Methods: Unilateral left lung transplantation was performed in male rats (Brown-Norway to Fischer F344, 200-250 g body weight). For immunosuppression, the following subtherapeutic doses were used: calcitriol 0.5 μg/kg/day, cyclosporine A 2.5 mg/kg/day i.p., and tacrolimus 40 μg/kg i.m. Five groups (n=5) were analyzed: cyclosporine A; cyclosporine A and calcitriol; calcitriol; tacrolimus and calcitriol; and tacrolimus. The injections were performed for 5 days starting from the day of transplantation. Recipients were sacrificed on day 5 post-transplant. The contralateral right main bronchus and pulmonary artery were occluded for 5 min and blood was drawn for blood gas analysis. The grafts were excised, fixed in formaline and embedded in paraffin. Histological evaluation was done in blinded fashion (ISHLT 1999/rank scale). The mean and standard error of the mean (PaO2) or the median and range (rejection grading) are given. ANOVA followed by planned comparison for the PaO2 and Kruskal-Wallis ANOVA for rejection grading were applied, p<0.05 considered significant. Results: Arterial PaO2 on day 5 was very low in animals treated with subtherapeutic dosages of either cyclosporine A (48±10 mmHg), calcitriol (51±3) or tacrolimus (86±22). Combined treatment with cyclosporine A and calcitriol revealed a significant improvement (248±78; p<0.05 vs. other groups), whereas the combination of tacrolimus with calcitriol did not reveal any benefit (65±9). Rejection grading with these subtherapeutic doses did not show any significant difference between groups. Conclusions: Our data indicate that cyclosporine A, but not tacrolimus, has a strong additive effect with calcitriol on acute rat lung allograft rejection